Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia Trial N/A Unknown Oct. 18, 2015
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. Trial Phase 3 Completed Oct. 18, 2015
Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients Trial Phase 2 Completed Oct. 11, 2015
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease Trial Phase 1 Terminated Oct. 5, 2015
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease Trial Phase 1 Completed Oct. 1, 2015
Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease - Evolution Trial N/A Completed Sept. 29, 2015
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease Trial Phase 2 Unknown Sept. 28, 2015
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon Trial Phase 3 Completed Sept. 17, 2015
Efficacy of Acupuncture and Bee Venom Acupuncture on Patients With Idiopathic Parkinson's Disease Trial N/A Completed Sept. 8, 2015
Assessment of Social-emotional Functioning in Neurological Diseases Trial N/A Completed Sept. 6, 2015
Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine Trial N/A Unknown Aug. 25, 2015
Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone Trial Phase 1 Completed Aug. 20, 2015